Navigation Links
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Date:3/11/2009

KING OF PRUSSIA, Pa., March 11 /PRNewswire/ -- CSL Behring has been informed by the U.S. Food and Drug Administration (FDA) that because RiaSTAP(TM) is the first FDA-approved treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, the company is entitled to seven years of orphan-drug exclusivity. RiaSTAP was approved by the FDA in January and is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Approval was based on a pivotal phase II prospective, open-label pharmacokinetic (PK) and safety study using maximum clot firmness as a surrogate endpoint for hemostatic efficacy.

"As a leader in developing safe, effective and high-quality biologic therapies, CSL Behring is committed to meeting the needs of patients with rare disorders," said Paul Perreault, Executive Vice President of CSL Behring's Worldwide Commercial Operations. "As the only company with an FDA approved treatment for congenital fibrinogen deficiency, CSL Behring will work closely with the healthcare community to ensure that all patients have access to RiaSTAP."

In its letter to CSL Behring, the FDA expressed the agency's gratitude that the company had developed RiaSTAP, explaining: "The entire premise of the orphan products program is based on the realization that the resources and commitment devoted to the development of drugs for 'orphan' populations may not provide financial return to their sponsors."

Congenital fibrinogen deficiency is a rare, potentially life-threatening bleeding disorder that affects an estimated one person per million, with an estimated prevalence in the U.S. of approximately 300 patients. Symptoms of congenital fibrinogen deficiency include excessive bleeding following injury, bruising, bleeding of the umbilical cord at birth and from the site of the umbilical stump in a newborn, spon
'/>"/>

SOURCE CSL Behring
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
3. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
4. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
5. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
6. deCODE Receives California Clinical Laboratory License
7. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
8. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
9. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
10. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
11. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... TUCSON, Ariz. , Aug. 20, 2014 /PRNewswire/ ... of the  Roche  Group, today announced that its ... been CE marked in the European Union for ... specimens. The system, consisting of VENTANA Virtuoso software ... the VENTANA iScan HT slide scanner, provides automated ...
(Date:8/20/2014)... Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces that ... has received Chinese FDA (CFDA) approval and has ... into the China domestic ... distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd., ... FDA approved and China CFDA certified oral solid ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Market for Medical Devices ... The European, Middle Eastern and African markets represent ... part of its coverage, this study: The Market ... EMEA medical device markets and estimates markets for ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
... 19 Stallergenes S.A.,today announced that the Paul ... biological products, has approved its application for a,pediatric ... Grasses,sublingual tablets for desensitization to grass pollens. , ... adults was granted on June 24, 2008.,Oralair(R) Grasses ...
... the international,investment house specialising in medical sciences, said ... pioneering stem cell treatments if it is,to remain ... Professor Sir Christopher Evans, founder ... plc has received approval from the UK,Medicines and ...
Cached Medicine Technology:STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany 2STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany 3STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany 4UK Must Maintain its Momentum in Stem Cell Expertise 2
(Date:8/20/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Recently, Top10BestSEOHosting.com has compared many Linux ... and Bluehost are the most recommended suppliers for ...
(Date:8/20/2014)... Today, Zane Benefits, the #1 ... a new eBook, Affordable Care Act 101. , ... feel uncertain about how the ACA impacts their ... line. , The new eBook outlines key ACA ... their upcoming health insurance decisions. , Read the ...
(Date:8/20/2014)... -- A group representing U.S. obstetricians is calling for ... According to the American College of Obstetricians and Gynecologists ... the safety and effectiveness of flu vaccination during pregnancy. ... be particularly dangerous to pregnant women, as it can ... Riley, chair of the college,s Immunization Expert Work Group, ...
(Date:8/20/2014)... than 42 percent of women underwent breast reconstruction ... associated with foregoing reconstruction included being black, having ... Author: Monica Morrow, M.D., of the Memorial Sloan ... Background: The Women,s Health and Cancer Rights Act ... following a mastectomy. Still, most women who undergo ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Hundreds of ... behalf of women who were allegedly injured due to ... in New Jersey’s Bergen County Superior Court, Bernstein Liebhard ... on August 15, 2014, the Court has established procedures ... Mirena lawsuits that are part of the proceeding’s initial ...
Breaking Medicine News(10 mins):Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4
... , THURSDAY, Nov. 24 (HealthDay News) -- Black Friday, the ... the quest as it is about getting good deals, according ... the Black Friday adventure phenomenon, the more fun you,re likely ... professor at Wake Forest University, said in a university news ...
... THURSDAY, Nov. 24 (HealthDay News) -- The holiday season can ... there are a number of things they can do to ... because many traditional holiday foods contain such allergens as wheat, ... news release from the American College of Allergy, Asthma and ...
... or processed meat is positively associated with aggressive prostate cancer, ... journal PLoS ONE . The research ... Francisco, also found that the correlation was primarily driven by ... done. They suggest that this result, which was ...
... HealthDay Reporter , WEDNESDAY, Nov. 23 (HealthDay ... not an asthma diagnosis are often prescribed inhaled steroid ... those medications on an as-needed basis instead of every ... wheezing in young children, and the treatment for some ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... that the drug company Merck will pay $950 million to ... which was pulled from the market in 2004 after studies ... stroke. Merck will pay $321.6 million in criminal ...
... the numbers indicate that improvements are possible," says Hyland at ... in Boston, USA, 234 million major surgical procedures are conducted ... human beings undergoes a major surgical procedure each year. ... According to the WHO, serious complications occur in three to ...
Cached Medicine News:Health News:Allergy Sufferers Should Prepare for Holiday Triggers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 3Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 2Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 3Health News:Creating safer surgery to save more lives 2Health News:Creating safer surgery to save more lives 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: